BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//White City Innovation District - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:White City Innovation District
X-ORIGINAL-URL:https://www.whitecityinnovationdistrict.org.uk
X-WR-CALDESC:Events for White City Innovation District
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250501T173000
DTEND;TZID=Europe/London:20250501T203000
DTSTAMP:20260421T110210
CREATED:20250416T160126Z
LAST-MODIFIED:20250416T175311Z
UID:3490-1746120600-1746131400@www.whitecityinnovationdistrict.org.uk
SUMMARY:Deep Tech Industry Showcase
DESCRIPTION:Deep Tech Network Industry Showcase is back! \nImperial College London and Nexus invite you to the White City Innovation District to hear from and network with leading deep tech innovators. \nIf you’re part of a science\, tech\, or engineering startup\, business or academic institution\, this event is for you. Spaces are limited\, so don’t miss out! \nProgramme:\n17:30 – Registration + networking over refreshments\n18:00 – Talks begin\n19:15 – Networking drinks + pizza\n20:30 – End \nSPEAKERS\nPROFESSOR DARIO FARINA (Co-Founder\, & Scientific Adviser of Neubond; Chair in Neurorehabilitation Engineering\, Imperial College London) \nDario was Professor at Aalborg University in Denmark\, and at the University Medical Center at Georg-August University\, Germany\, where he founded and directed the Institute of Neurorehabilitation Systems until he moved to Imperial College London as Chair in Neurorehabilitation Engineering. His research focuses on biomedical signal processing\, neurorehabilitation technology\, and neural control of movement. Within these areas\, he has (co)-authored approximately 400 papers in peer-reviewed Journals and >500 conference abstract and papers. \nDario is co-founder or Neubond\, which specialises in personalised home rehabilitation devices for stroke patients to address their mobility constraints. Its innovative devices establish a direct connection to the patient’s body\, seamlessly integrating effective therapy into their daily lives. \nDR. CHIARA BOARD (Founder & CEO\, P.Happi) \nChiara is Founder & CEO of P.Happi\, biotech company developing microbiome-based intimate health products created for women by team of female scientists. Its patent-pending\, science-backed technology is now available at p-happi.com! \nChiara has a PhD in Chemical Engineering\, Synthetic Biology where she developed a mammalian cell-free protein synthesis platform to accelerate the screening of industrially relevant antibodies from AstraZeneca. Demonstrated history of working in R&D. \nChiar was previously a Marit Mohn Scholar\, Scholar of the German Academic Scholarship Foundation\, and is Founder of WOMENinSTEM@IC\, a networking platform for female academics at Imperial College London. \nNICK GREENHALGH (Co-Founder & CEO of Luca Health) \nNick is an ex-professional rugby player who had to retire aged just 20 due to injury. He now uses his experience from pro sport as fuel to help protect and support the next generation through his important work on concussion at Luca\, a Hammersmith-based health-tech. \nLuca empowers schools to manage head injuries with confidence and deliver their sports programmes safely. It combines cutting-edge smartphone technology\, artificial intelligence\, and an intuitive desktop dashboard with expert medical oversight to provide seamless\, end-to-end concussion management. \nIts integrated\, three-pronged approach removes uncertainty from the recovery process\, giving schools clarity\, compliance\, and peace of mind. \nDR. TOINET CRONJE (Director of Translational Sciences\, Sequoia Genetics) \nToinét is Director of Translational Sciences at Sequoia Genetics – experts in leveraging genetic data for generating translational insights. Sequoia works with academia\, investors\, pharma and biotech by performing research that leverages genetic data to help inform drug discovery and development. \nIts team is made up of biologists\, clinicians\, epidemiologists\, statisticians\, data scientists\, bioinformaticians and industry experts that have collectively published hundreds of research papers in the field and are vastly experienced in translating genetic insights to guide clinical development decisions. \nToinét earned a PhD in Health Science from North-West University\, South Africa\, focusing on DNA methylation as a mediator between urbanization and cardiometabolic disease. She spent three years as a postdoctoral researcher at the University of Copenhagen\, working with proteomic data as disease biomarkers\, and later shifted to drug target Mendelian randomization in both academic and industry roles. \nDANIEL SIMILAKI (Founder\, ACCSN – Afro Caribbean Commercial Science Network) \nDaniel is Founder of ACCSN\, the first professional network dedicated to raising the black and ethnic representation in the commercial science industry. \nIt was formed to support the development of aspiring and current professionals in the industry\, make the commercial route more attractive for black and ethnic minorities\, ultimately raising the representation whilst providing a space through which they can thrive together. The ACCSN works with a diverse pool of aspiring and current professionals\, corporate sponsors and educational institutions to bring about this mission. \nIn his day job\, Daniel works for Avantor\, a Fortune 500 company and global provider of products and services to customers in the biopharma\, healthcare\, education & government\, and advanced technologies & applied materials industries. \nION IOANNOU (Co-Founder\, RemePhy Technologies) \nIon is co-founder and board member at RemePhy technologies\, an early-stage Imperial spinout developing metal-hyperaccumulating plants in order to purify contaminated soils and recycle heavy metals. RemePhy’s sustainable solution accelerates land restoration for the mining industry and agriculture\, enables the safe redevelopment of industrial sites and strengthens the critical mineral supply chain. \nIon has a PhD in chemical biology from Imperial\, where he he specialised in SynBio and artificial cells. Interested in deep teck that tackles global challenges.
URL:https://www.whitecityinnovationdistrict.org.uk/event/deep-tech-industry-showcase/
LOCATION:I-HUB\, Imperial White City Campus\, 84 Wood Lane\, London\, W12 0BZ\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://www.whitecityinnovationdistrict.org.uk/wp-content/uploads/sites/10/2025/04/Jawdrop-smaller-PNG.jpg
ORGANIZER;CN="Nexus":MAILTO:hello@move-upstream.org.uk
END:VEVENT
END:VCALENDAR